Robert Peach

Biography

Dr Peach is co­founder of Receptos, a​ publicly listed biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases. Si​nce 2011, he has held the role of Chief Scientific Officer. From 2007 to 2009, Dr. Peach co­-founded and served as the Vice President of Biology for Apoptos, Inc., which Receptos acquired in May 2009. From 2005 to 2007, Dr. Peach was Senior Director of Oncology Discovery at Biogen Idec where he had responsibility for several bicoastal research programs. From 2001 to 2005, Dr. Peach served as Director of Antibody Discovery and Tumor Immunology at IDEC Pharmaceuticals and at the merged Biogen Idec where he worked on developing new autoimmune and oncology therapeutic opportunities. Prior to joining Biogen Idec, Dr. Peach held several research positions with increasing responsibility at Bristol Myers Squibb from 1991 to 2000. He received his B.S. and M.S. (1st class honors) from the University of Canterbury and a Ph.D. in Biochemistry from the University of Otago, New Zealand.

Research Interest

 Cancer